Progyny, Inc. (NASDAQ:PGNY) Stake Trimmed by Leibman Financial Services Inc.

Leibman Financial Services Inc. lowered its holdings in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 28.5% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 45,433 shares of the company's stock after selling 18,076 shares during the period. Leibman Financial Services Inc. owned about 0.05% of Progyny worth $1,015,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of PGNY. River Road Asset Management LLC acquired a new position in shares of Progyny during the fourth quarter valued at $25,529,000. Barclays PLC lifted its position in Progyny by 95.7% in the 4th quarter. Barclays PLC now owns 1,382,205 shares of the company's stock valued at $23,843,000 after purchasing an additional 676,048 shares during the last quarter. D. E. Shaw & Co. Inc. acquired a new position in Progyny during the 4th quarter valued at about $11,265,000. BNP Paribas Financial Markets bought a new position in Progyny in the 4th quarter worth about $10,557,000. Finally, First Sabrepoint Capital Management LP bought a new position in Progyny in the 4th quarter worth about $9,660,000. Institutional investors own 94.93% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on PGNY shares. BTIG Research raised Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price target on the stock in a report on Monday, March 31st. Bank of America lifted their target price on Progyny from $21.00 to $25.00 and gave the company a "buy" rating in a research note on Tuesday, February 11th. Finally, Canaccord Genuity Group decreased their price target on Progyny from $23.00 to $21.00 and set a "hold" rating for the company in a research note on Monday, May 12th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, Progyny has a consensus rating of "Hold" and an average price target of $23.45.

Progyny Trading Up 1.5%

NASDAQ:PGNY traded up $0.32 during mid-day trading on Friday, reaching $21.68. 509,321 shares of the stock were exchanged, compared to its average volume of 1,706,096. The business has a fifty day moving average price of $22.02 and a 200 day moving average price of $20.35. Progyny, Inc. has a 1-year low of $13.39 and a 1-year high of $30.42. The firm has a market capitalization of $1.86 billion, a PE ratio of 37.38, a PEG ratio of 2.39 and a beta of 1.37.

Progyny (NASDAQ:PGNY - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.28). Progyny had a net margin of 5.03% and a return on equity of 11.36%. The business had revenue of $324.04 million for the quarter, compared to the consensus estimate of $307.86 million. During the same quarter last year, the business posted $0.17 EPS. The business's revenue for the quarter was up 16.5% on a year-over-year basis. On average, sell-side analysts forecast that Progyny, Inc. will post 0.6 earnings per share for the current year.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.